BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harikrishnan S, Mohanan PP, Chopra VK, Ambuj R, Sanjay G, Bansal M, Chakraborty RN, Chandra S, Chattarjee SS, Chopra HK, Mathew C, Deb PK, Goyal A, Goswami KC, Gupta R, Guha S, Gupta V, Hasija PK, Wardhan H, Jabir A, Jayagopal PB, Kahali D, Katyal VK, Kerkar PG, Khanna NN, Majumder B, Mandal M, Meena CB, Naik N, Narain VK, Pathak LA, Ray S, Roy D, Routray SN, Sarma D, Shanmugasundaram S, Singh BP, Tyagi SK, Venugopal K, Wander GS, Yadav R, Das MK. Cardiological society of India position statement on COVID-19 and heart failure. Indian Heart J 2020;72:75-81. [PMID: 32405088 DOI: 10.1016/j.ihj.2020.04.012] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
Number Citing Articles
1 Salabei JK, Asnake ZT, Ismail ZH, Charles K, Stanger G, Abdullahi AH, Abraham AT, Okonoboh P. COVID-19 and the Cardiovascular System: An Update. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.01.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Puttegowda B, Shivashankarappa AB, Dutta S, Chikkamuniswamy R, Bhat P, Krishnan S, Nanjappa MC. Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre. Indian Heart J 2021;73:682-6. [PMID: 34695446 DOI: 10.1016/j.ihj.2021.10.007] [Reference Citation Analysis]
3 Akter F, Araf Y, Naser IB, Promon SK. Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury. Regen Ther 2021;18:447-56. [PMID: 34608441 DOI: 10.1016/j.reth.2021.09.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yin J, Wang S, Liu Y, Chen J, Li D, Xu T. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 2021;:e12718. [PMID: 34013612 DOI: 10.1111/micc.12718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
6 Erol N, Alpinar A, Erol C, Sari E, Alkan K. Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children. Cardiol Young 2021;:1-7. [PMID: 34407902 DOI: 10.1017/S1047951121003693] [Reference Citation Analysis]
7 Keri VC, Hooda A, Kodan P, R L B, Jorwal P, Wig N. Intricate interplay between Covid-19 and cardiovascular diseases. Rev Med Virol 2021;31:e2188. [PMID: 33128859 DOI: 10.1002/rmv.2188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, Pal I, Patel N, Amgai B, Ghosh RK, Fonarow GC, Lavie CJ, Naidu SS. COVID-19 Pandemic: Cardiovascular Complications and Future Implications. Am J Cardiovasc Drugs 2020;20:311-24. [PMID: 32578167 DOI: 10.1007/s40256-020-00420-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 29.5] [Reference Citation Analysis]
9 Popiolek-Kalisz J, Kalisz G. Cardiac Resynchronization Therapy Remote Monitoring - COVID-19 Pandemic Experiences and Future Perspectives. Curr Probl Cardiol 2021;:100874. [PMID: 33994038 DOI: 10.1016/j.cpcardiol.2021.100874] [Reference Citation Analysis]
10 Li X, Wang H, Zhao R, Wang T, Zhu Y, Qian Y, Liu B, Yu Y, Han Y. Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings. Radiology 2021;299:E230-40. [PMID: 33434112 DOI: 10.1148/radiol.2021203998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]